1. Guillot, J., N. Falette, S. Courtois, T. Voeltzel, E. Garcia, M. Ozturk, and A. Puisieux (1996) Alteration of p53 damage response by tamoxifen treatment. Clin. Cancer Res. 2: 1439–1444.
2. Turini, M. E. and R. N. DuBois (2002) Cyclooxygenase-2: A therapeutic target. Annu. Rev. Med. 53: 35–57.
3. Chan, G., J. O. Boyle, E. K. Yang, F. Zhang, P. G. Sacks, J. P. Shah, D. Edelstein, R. A. Soslow, A. T. Koki, B. M. Woerner, J. I. Masferrer, and A. J. Dannenberg (1999) Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59: 991–994.
4. Tucker, O. N., A. J. Dannenberg, E. K. Yang, F. Zhang, L. Teng, J. M. Daly, R. A. Soslow, J. I. Masferrer, B. M. Woerner, A. T. Koki, and T. J. Fahey (1999) Cyclooxygenase-2 expression is upregulated in human pancreatic cancer. Cancer Res. 59: 987–990.
5. Ristimaki, A., A. Sivula, J. Lundin, M. Lundin, T. Salminen, C. Haglund, H. Joensuu, and J. Isola (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 62: 632–635.